Clinicopathological Correlation of Keratinocyte Growth Factor and Matrix Metalloproteinase-9 Expression in Human Gastric Cancer

Brenner H. , Rothenbacher D. , Arndt V. Epidemiology of stomach cancer. Methods Mol Biol. 2009; 472: 467–477.

Jemal A. , Bray F. , Center M.M. , Ferlay J. , Ward E. , Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69–90.

Kim K.H. , Lee K.W. , Baek S.K. Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy. Gastric Cancer. 2011; 14(2): 130–138.

Seshadri R.A. , Jayanand S.B. , Ranganathan R. Prognostic factors in patients with node-negative gastric cancer: an Indian experience. World J Surg Oncol. 2011; 9: 48.

Ahn H.S. , Lee H.J. , Yoo M.W. Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period. Br J Surg. 2011; 98(2): 255–260.

Ornitz D.M. , Itoh N. Fibroblast growth factors. Genome Biol. 2001; 2(3): REVIEWS3005.

Finch P.W. , Rubin J.S. , Miki T. , Ron D. , Aaronson S.A. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science. 1989; 245(4919): 752–755.

Rubin J.S. , Osada H. , Finch P.W. , Taylor W.G. , Rudikoff S. , Aaronson S.A. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA. 1989; 86(3): 802–806.

Miki T. , Fleming T.P. , Bottaro D.P. , Rubin J.S. , Ron D. , Aaronson S.A. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science. 1991; 251(4989): 72–75.

Finch P.W. , Rubin J.S. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res. 2004; 91: 69–136.

Bottaro D.P. , Rubin J.S. , Ron D. , Finch P.W. , Florio C. , Aaronson S.A. Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem. 1990; 265(22): 12767–12770.

Siddiqi I. , Funatomi H. , Kobrin M.S. , Friess H. , Büchler M.W. , Korc M. Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun. 1995; 215(1): 309–315.

Ishiwata T. , Friess H. , Büchler M.W. , Lopez M.E. , Korc M. Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol. 1998; 153(1): 213–222.

Toyokawa T. , Yashiro M. , Hirakawa K. Co-expression of keratinocyte growth factor and K-sam is an independent prognostic factor in gastric carcinoma. Oncol Rep. 2009; 21(4): 875–880.

Park H.I. , Ni J. , Gerkema F.E. , Liu D. , Belozerov V.E. , Sang Q.X. Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. J Biol Chem. 2000; 275(27): 20540–20544.

Rundhaug J.E. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005; 9(2): 267–285.

Stetler-Stevenson W.G. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am. 2001; 10(2): 383–392, x.

Nabeshima K. , Inoue T. , Shimao Y. , Sameshima T. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int. 2002; 52(4): 255–264.

Ueda Y. , Imai K. , Tsuchiya H. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am J Pathol. 1996; 148(2): 611–622.

Tang Y. , Zhu J. , Chen L. , Chen L. , Zhang S. , Lin J. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer. Clin Cancer Res. 2008; 14(9): 2870–2877.

Zhao Z.S. , Wang Y.Y. , Ye Z.Y. , Tao H.Q. Prognostic value of tumor-related molecular expression in gastric carcinoma. Pathol Oncol Res. 2009; 15(4): 589–596.

Hermanek P. , Sobin L.H. International Union against Cancer TNM classification of malignant tumours, 4th fully revised edition. Berlin, New York: Springer-Verlag; 1987.

Ajani J. , D'Amico T.A. , Hayman J.A. , Meropol N.J. , Minsky B. ; National Comprehensive Cancer Network. Gastric cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2003; 1(1): 28–39.

Finch P.W. , Cunha G.R. , Rubin J.S. , Wong J. , Ron D. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn. 1995; 203(2): 223–240.

Mason I.J. , Fuller-Pace F. , Smith R. , Dickson C. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech Dev. 1994; 45(1): 15–30.

Orr-Urtreger A. , Bedford M.T. , Burakova T. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol. 1993; 158(2): 475–486.

Thomson A.A. , Foster B.A. , Cunha G.R. Analysis of growth factor and receptor mRNA levels during development of the rat seminal vesicle and prostate. Development. 1997; 124(12): 2431–2439.

Finch P.W. , Rubin J.S. Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst. 2006; 98(12): 812–824.

Watanabe M. , Ishiwata T. , Nishigai K. , Moriyama Y. , Asano G. Overexpression of keratinocyte growth factor in cancer cells and enterochromaffin cells in human colorectal cancer. Pathol Int. 2000; 50(5): 363–372.

Tani H. , Saito N. , Kobayashi M. , Kameoka S. Clinical significance of keratinocyte growth factor and K-sam gene expression in gastric cancer. Mol Med Rep. 2013; 7(5): 1381–1386.

Liotta L.A. , Stetler-Stevenson W.G. Metalloproteinases and cancer invasion. Semin Cancer Biol. 1990; 1(2): 99–106.